Dianthus Therapeutics, Inc. short interest in 2026
In 2026, Dianthus Therapeutics, Inc.'s disclosed short interest ran from 17.21% of shares outstanding on 15 Jan 2026 to 15.79% on 15 Sep 2026, a change of -1.42 percentage points. The year's high was 21.44% on 30 Jun 2026 and its low 14.46% on 15 May 2026, averaging 17.44% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.31 days on 31 Aug 2026. Full history: Dianthus Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 17.21% (15 Jan 2026)
- End of year
- 15.79% (15 Sep 2026)
- Change
- -1.42 pp
- High
- 21.44% (30 Jun 2026)
- Low
- 14.46% (15 May 2026)
- Average
- 17.44%
- Highest days to cover
- 15.31 (31 Aug 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 17.21% | 8.69 | results (8-K) |
| 30 Jan 2026 | 19.36% | 8.18 | |
| 13 Feb 2026 | 18.90% | 13.02 | |
| 27 Feb 2026 | 18.41% | 13.84 | |
| 13 Mar 2026 | 20.67% | 4.76 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 20.39% | 7.36 | |
| 15 Apr 2026 | 14.76% | 8.33 | |
| 30 Apr 2026 | 14.73% | 14.14 | |
| 15 May 2026 | 14.46% | 14.27 | 10-Q filed, results (8-K) |
| 29 May 2026 | 15.04% | 10.88 | |
| 15 Jun 2026 | 15.69% | 5.69 | |
| 30 Jun 2026 | 21.44% | 5.47 | |
| 15 Jul 2026 | 20.73% | 8.86 | |
| 31 Jul 2026 | 18.84% | 9.49 | |
| 14 Aug 2026 | 15.05% | 11.54 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 15.07% | 15.31 | |
| 15 Sep 2026 | 15.79% | 14.42 |
See also: Dianthus Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.